Navegar

Colección

Datos Estadísticas

Lista de

Drug Resistance, Neoplasm
8
"Binding of modulators to mouse and human multidrug resistance P-glycoprotein. A computational study" (2013) Jara, G.E.; Vera, D.M.A.; Pierini, A.B. Journal of Molecular Graphics and Modelling. 46:10-21
"Reversal of antiprogestin resistance and progesterone receptor isoform ratio in acquired resistant mammary carcinomas" (2009) Wargon, V.;Helguero, L.A.;Bolado, J. (...)Lanari, C. Breast Cancer Research and Treatment. 116(3):449-460
"ROS production by endogenously generated protoporphyrin IX in murine leukemia cells" (2009) Diez, B.;Cordo Russo, R.;Teijo, M.J. (...)Fukuda, H. Cellular and Molecular Biology. 55(2):15-19
"Invasive giant prolactinoma with loss of therapeutic response to cabergoline: Expression of angiogenic markers" (2009) Mallea-Gil, M.S.;Cristina, C.;Perez-Millan, M.I. (...)Becu-Villalobos, D. Endocrine Pathology. 20(1):35-40
"PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes" (2007) Cristina, C.;Díaz-Torga, G.S.;Goya, R.G. (...)Becu-Villalobos, D. Molecular Cancer. 6
"Dopaminergic D2 receptor knockout mouse: An animal model of prolactinoma" (2006) Cristina, C.;García-Tornadú, I.;Díaz-Torga, G. (...)Bronstein M. Frontiers of Hormone Research. 35:50-63
"Reversal of estrogen-resistance in murine mammary adenocarcinomas" (1999) Montecchia, M.F.; Molinolo, A.; Lanari, C. Breast Cancer Research and Treatment. 54(2):93-99
"Reactivity of monoclonal antibody FC-2.15 against drug resistant breast cancer cells. Additive cytotoxicity of adriamycin and taxol with FC-2.15" (1998) Ballaré, C.;Portela, P.;Schiaffi, J. (...)Mordoh, J. Breast Cancer Research and Treatment. 47(2):163-170